Searchable abstracts of presentations at key conferences in endocrinology

ea0063p255 | Pituitary and Neuroendocrinology 1 | ECE2019

Trunk fat increase is prevented both in patients undergoing long-lasting continuous r-hGH therapy and in those who discontinued r-hGH compared to untreated patients: results from baseline data of the MAGHD study

Monzani Maria Laura , Magnani Elisa , Diazzi Chiara , Pederzoli Simone , Volpi Laura , Rochira Vincenzo

Background: Adult growth hormone (GH) deficiency (AGHD) is related with alterations in body composition, increased abdominal and visceral adiposity, adverse change in lipid and carbohydrate metabolism, and reduction of bone mineral density (BMD).Aim: To compare baseline outcomes concerning body composition and biochemical/hormonal data among adult patients with AGHD referring to a single endocrinological center and grouped according to their history of r...

ea0070aep610 | Pituitary and Neuroendocrinology | ECE2020

Importance of sexual function assessment in multidimensional evaluation of AGHD patients: Baseline results from the management of adult growth hormone deficiency (MAGHD) study

Laura Monzani Maria , Pederzoli Simone , Volpi Laura , Magnani Elisa , Diazzi Chiara , Rochira Vincenzo

Background: Patients with adult growth hormone deficiency (AGHD) have impaired health-related quality of life (QoL). While the effects of reduced muscle mass and vitality-loss on QoL have been well characterized in AGHD, the impact of AGHD on sexual function, a recognized factor influencing well-being, has never been deepened.Aim: To investigate the prevalence of sexual dysfunction in AGHD patients referring to a single endocrinological center and groupe...

ea0056p794 | Pituitary - Clinical | ECE2018

A comparison of pituitary function in primary and secondary empty sella: preliminary data

Magnani Elisa , Chiara Decaroli Maria , Leoni Laura , Diazzi Chiara , Rochira Vincenzo

Background: Empty sella (ES), the herniation of the subarachnoid space within sella associated with a variable flattening of the pituitary gland, is classified as primary (PES) or secondary (SES) on the basis of etiological factors.Aim: To assess the differences between PES and SES in terms of pituitary function.Methods: Clinical, radiological and hormonal data were retrospectively extrapolated from the records of 85 patients with ...

ea0081p167 | Pituitary and Neuroendocrinology | ECE2022

Patient-reported outcomes (PRO) in adult growth hormone deficiency (aghd) for an improved patients’ management: results from the management of AGHD(MAGHD) study

Monzani Maria Laura , Pederzoli Simone , Bellelli Alessio , Magnani Elisa , Diazzi Chiara , Golinelli Caterina , Pacchioni Marco , Orsini Mirko , Rochira Vincenzo

Background: AGHD is a recognized clinical entity, but symptoms are quite nonspecific; the lack of objective tools able to measure patientsÂ’ health status remains the main barrier in clinical monitoring and treatment.Aim: The MAGHD Study aims improving AGHD patientsÂ’ management through a Smartphone app (MAGHDApp) and a fit-watch integrated with a software framework able to merge daily data of patientsÂ’ well-being and physical activity with ...

ea0032p1088 | Thyroid cancer | ECE2013

Pre-miR146a expression profiling of follicular thyroid carcinoma

Pignatti Elisa , Vighi Eleonora , Roncati Luca , Kara Elda , Porcheddu Eleonora , Magnani Elisa , Rochira Vincenzo , Maiorana Antonino , Carani Cesare , Simoni Manuela

Introduction: Follicular thyroid carcinomas (FTC) are the second most common type of thyroid malignancy. Micro-RNAs (miRNAs) are a new class of small, noncoding RNAs whose expression is deregulated in many types of human cancers and may lend novel clues to FTC genesis. Pre-miR146a represents one of the most up-regulated miRNAs in papillary thyroid carcinomas (PTC) and a SNP (rs2910164), identified in pre-miR146a, contributes to genetic predisposition to PTC, but data on FTC ar...

ea0032p1092 | Thyroid cancer | ECE2013

Mutations and somatic changes in the genotype of rs2910164 in pre-miR146a are frequent in follicular thyroid carcinoma

Vighi Eleonora , Pignatti Elisa , Roncati Luca , Rochira Vincenzo , Kara Elda , Madeo Bruno , Magnani Elisa , Maiorana Antonino , Carani Cesare , Simoni Manuela

Introduction: The mechanism underlying the development of follicular thyroid carcinoma (FTC), the second commonest thyroid tumor, is still unknown. An interesting hypothesis is that changes in the expression of multiple regulatory RNA (miR) genes may be a major mechanism in thyroid carcinogenesis. For example, several studies suggested that SNP rs2910164 in the pre-miR146a, a precursor of miR146a, might be correlated to papillary carcinoma. The aim of this study was the evalua...

ea0016p137 | Clinical cases | ECE2008

A novel compound heterozygous mutation of the aromatase gene in adult man: new insight into the role of estrogen on gonadal development

Lanfranco Fabio , Zirilli Lucia , Baldi Matteo , Luberto Alessandra , Pignatti Elisa , Magnani Francesca , Aimaretti Gianluca , Carani Cesare , Rochira Vincenzo

We present a novel heterozygous compound inactivating mutation of the CYP19A1 (P450arom) gene in a 26-year-old 46-XY Caucasian Italian male leading to aromatase deficiency. The patient phenotype resembled those observed in the other estrogen-deficient patients: tall stature with continuing linear growth, bilateral genu valgum, unfused epiphyses and delayed bone age, osteopenia. A dysmetabolic syndrome characterized by overweight (BMI 29), hyperinsulinaemia, low serum HDL and i...

ea0090p687 | Pituitary and Neuroendocrinology | ECE2023

Smartphone App on Follow-up of Adult Growth Hormone Deficiency (AGHD) Patients: Results From the Management of AGHD (MAGHD) Study

Bellelli Alessio , Golinelli Caterina , Laura Monzani Maria , Pederzoli Simone , Magnani Elisa , Beltrami Elisa , Pacchioni Marco , Orsini Mirko , Diazzi Chiara , De Vincentis Sara , Rochira Vincenzo

Background: AGHD significantly impacts on metabolism, body composition and quality of life (QoL), including sexuality.AIM: To investigate the impact of a smartphone App on AGHD monitoring, especially QoL and comorbidities as well as on both body composition and biochemical parameters.Methodology: 83 AGHD patients were enrolled in this prospective, open-label, monocentric study (MAGHD Study) of 24-month duration. Patients were evalu...

ea0035p1126 | Thyroid Cancer | ECE2014

TERT promoter mutations correlate with a more advanced stage at diagnosis and with a poorer prognosis in differentiated thyroid cancer

Colombo Carla , Muzza Marina , Rossi Stefania , Cirello Valentina , Perrino Michela , Tosi Delfina , Vigo Beatrice , Leo Simone De , Bulfamante Gaetano , Magnani Elisa , Pignatti Elisa , Simoni Manuela , Vicentini Leonardo , Fugazzola Laura

Telomerase is a ribonucleoprotein polymerase that maintains telomere ends and plays a role in cellular senescence, being repressed in postnatal somatic cells. Mutations C228T and C250T of the telomerase reverse transcriptase (TERT) were recently reported in human cancers. In thyroid cancer, TERT mutations are more frequent in aggressive histotypes, but very few data are available about the potential correlations with clinical features in papillary and follicular thyroid cancer...